Redmile Group »

Kalaris Therapeutics shares owned by Redmile Group

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Redmile Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $480k 83k 5.78
2025-06-30 $222k 83k 2.67
2025-03-31 $666k 83k 8.03